Pathophysiology of Pulmonary Arterial Hypertension

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

https://www.youtube.com/watch?v=9a4untSzLzg

An educational overview of three principal pathways—endothelin, nitric oxide, and prostacyclin—involved in the pathogenesis of pulmonary arterial hypertension (PAH).

This site is intended for U.S. healthcare professionals only. It features information about pulmonary arterial hypertension (PAH). PAH is defined hemodynamically as a mean pulmonary arterial pressure greater than or equal to 25 millimeters of mercury, with a pulmonary capillary wedge pressure of less than or equal to 15 millimeters of mercury.

Learn more about pulmonary arterial hypertension: http://bit.ly/1P75Bxf

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

pathophysiology, pulmonary arterial hypertension (PAH), Pulmonary hypertension (PHT)

Recent Posts


Recommended reading